SECreport

Form 4 ReShape Lifesciences For: Apr 13 Filed by: Armistice Capital Master Fund Ltd.

ReShape Lifesciences, Inc.  (RSLS) 
US:NASDAQ Investor Relations: ir.enteromedics.com